TELA Bio (NASDAQ: TELA) director Guido Neels granted stock and long-term options

Rhea-AI Filing Summary

TELA Bio director Guido J. Neels reported equity awards rather than open-market trades. On June 9, 2026, he received two grants of Common Stock totaling 23,600 shares after the larger grant and 11,925 shares after the second grant, both at $0.00 per share as compensation awards.

He also received two stock option grants covering 17,335 and 17,550 shares of Common Stock at an exercise price of $0.935 per share, expiring on June 9, 2036. The footnotes state these restricted stock units and options vest over time, generally in annual or monthly installments beginning on or before June 9, 2027, or earlier upon specified events, subject to his continued service.

Insights

Equity compensation analyst

Routine director equity grants with no open-market buying or selling.

The Form 4 shows Guido J. Neels, a director of TELA Bio, Inc., receiving stock and option awards as part of his compensation. All four entries use transaction code A, indicating grants or awards rather than market purchases or sales.

He received Common Stock awards at $0.00 per share and options with a $0.935 exercise price expiring on June 9, 2036. Footnotes describe multi-year vesting schedules tied to continued service and events such as a Change in Control. This appears to be standard board compensation, not a directional bet on the stock.

Because there are no sales and the awards vest over time, the filing mainly increases his long-term exposure to TELA Bio equity. Subsequent company filings may provide more detail on the overall equity incentive plan and how such grants fit into broader governance and pay practices.

Insider Trade Summary

4 transactions reported

Mixed 4 txns

Insider NEELS GUIDO J

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	17,550	$0.00	--
Grant/Award	Stock Option (Right to Buy)	17,335	$0.00	--
Grant/Award	Common Stock	11,925	$0.00	--
Grant/Award	Common Stock	11,675	$0.00	--

Holdings After Transaction: Stock Option (Right to Buy) — 17,550 shares (Direct, null); Common Stock — 11,925 shares (Direct, null)

Footnotes (1)

1. These restricted stock units will vest in three equal annual installments beginning on June 9, 2027, in each case subject to the Reporting Person's continued service through the applicable vesting date. These restricted stock units vest on the earlier of (a) June 9, 2027, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date. The option vests in 36 equal monthly installments on each monthly anniversary of June 9, 2026, in each case subject to the Reporting Person's continued service through the applicable vesting date. The option vests on the earlier of (a) June 9, 2027, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.

Key Figures

Common Stock grant 1: 11,675 shares at $0.00 Common Stock grant 2: 11,925 shares at $0.00 Stock option grant 1: 17,335 options at $0.935 +3 more

6 metrics

Common Stock grant 1 11,675 shares at $0.00 Award of Common Stock on June 9, 2026; 23,600 shares following

Common Stock grant 2 11,925 shares at $0.00 Award of Common Stock on June 9, 2026; 11,925 shares following

Stock option grant 1 17,335 options at $0.935 Right to buy Common Stock; expires June 9, 2036

Stock option grant 2 17,550 options at $0.935 Right to buy Common Stock; expires June 9, 2036

RSU vesting schedule 3 equal annual installments Beginning June 9, 2027, subject to continued service

Option vesting schedule 36 equal monthly installments On each monthly anniversary of June 9, 2026, subject to service

Key Terms

restricted stock units, Change in Control, Amended and Restated 2019 Equity Incentive Plan, vesting date, +1 more

5 terms

restricted stock units financial

"These restricted stock units will vest in three equal annual installments"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Change in Control financial

"the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan)"

A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.

Amended and Restated 2019 Equity Incentive Plan financial

"as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan"

vesting date financial

"subject to the Reporting Person's continued service through the applicable vesting date"

stock option (Right to Buy) financial

"Stock Option (Right to Buy)"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

NEELS GUIDO J

(Last) (First) (Middle)

C/O TELA BIO, INC.

1 GREAT VALLEY PARKWAY, SUITE 24

(Street)

MALVERN PENNSYLVANIA 19355

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TELA Bio, Inc. [ TELA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/09/2026		A		11,925(1)	A	$0	11,925	D
Common Stock	06/09/2026		A		11,675(2)	A	$0	23,600	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$0.935	06/09/2026		A		17,550		(3)	06/09/2036	Common Stock	17,550	$0	17,550	D
Stock Option (Right to Buy)	$0.935	06/09/2026		A		17,335		(4)	06/09/2036	Common Stock	17,335	$0	17,335	D

Explanation of Responses:

1. These restricted stock units will vest in three equal annual installments beginning on June 9, 2027, in each case subject to the Reporting Person's continued service through the applicable vesting date.

2. These restricted stock units vest on the earlier of (a) June 9, 2027, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.

3. The option vests in 36 equal monthly installments on each monthly anniversary of June 9, 2026, in each case subject to the Reporting Person's continued service through the applicable vesting date.

4. The option vests on the earlier of (a) June 9, 2027, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date.

	/s/ Megan Smeykal, Attorney-in-Fact	06/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did TELA (TELA) director Guido J. Neels report on this Form 4?

Guido J. Neels reported receiving equity compensation awards from TELA Bio, Inc. He acquired Common Stock and stock options as grants, not through open-market buying or selling, increasing his potential long-term ownership stake in the company subject to vesting conditions.

How many TELA Bio shares did Guido J. Neels acquire in stock grants?

He received two Common Stock awards on June 9, 2026. One grant left him holding 23,600 shares following the transaction, and the other left him holding 11,925 shares, with both awards granted at a price of zero dollars per share as compensation.

What stock options did Guido J. Neels receive from TELA Bio on June 9, 2026?

He was granted two stock option awards covering 17,335 and 17,550 shares of TELA Bio Common Stock. Both options have an exercise price of $0.935 per share and expire on June 9, 2036, providing long-dated potential ownership if exercised after vesting.

How do the TELA Bio restricted stock units granted to Guido J. Neels vest?

One restricted stock unit grant vests in three equal annual installments beginning June 9, 2027, conditioned on continued service. Another vests on the earlier of June 9, 2027, the next annual stockholder meeting, or a Change in Control, also requiring continued service to each vesting date.

What are the vesting terms of the TELA Bio stock options granted to Guido J. Neels?

One option grant vests in 36 equal monthly installments beginning on the monthly anniversary of June 9, 2026. The other vests on the earlier of June 9, 2027, the next annual stockholder meeting, or a Change in Control, in each case requiring continued service to vest.